Palazestrant, CAS [[2092925-89-6]]

Produktübersicht

• Artikelname: Palazestrant, CAS [[2092925-89-6]]
• Artikelnummer: TGM-T72945
• Hersteller Artikelnummer: T72945
• Alternativnummer: TGM-T72945-1MLX10MM(INDMSO),TGM-T72945-1MG,TGM-T72945-5MG,TGM-T72945-10MG,TGM-T72945-25MG,TGM-T72945-50MG,TGM-T72945-100MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: OP1250 , OP 1250 , OP-1250

Produktbeschreibung

Palazestrant (OP-1250) is an orally available and highly potent estrogen receptor antagonist and selective ER degrader with antitumor activity.Palazestrant inhibits 17b-estradiol (E2), inhibits MCF7 and CAMA-1 cell proliferation, and can be used in breast cancer research.

Produkteigenschaften

• Molekulargewicht: 449.6
• Reinheit: 97.55%
• CAS Nummer: [2092925-89-6]
• Formel: C28H36FN3O
• Target-Kategorie: Estrogen/progestogen Receptor|||Estrogen Receptor/ERR

Bilder

T72945